分泌抗禽呼肠孤病毒单克隆抗体杂交瘤细胞株的建立与鉴定

采用腹腔的接种１次脾内注射禽呼肠孤病毒（ＡＲＶ）蛋白免疫小鼠，经３次融合后，共筛选８株分泌抗禽呼肠孤病毒（单克隆抗体杂交瘤细胞株，这８株ＭｃＡｂ均可与ＡＲＶＳ１１３３株，ＦＤＯ株发生反应，而与ＩＢＤＶ，ＭＤＶ，ＥＤＳ－７６病毒不发生反应，经亚类鉴定，ＡＥ７，ＡＦ８，ＢＤ１，ＤＨ１０，ＥＥ５为ＩｇＧ１；ＡＤ６，ＣＧ４为ＩｇＣ２ａ，ＡＧ７为ＩｇＧ２ｂ。腹水效价在１０＾３～１０＾５之间。     

抗伪狂犬病病毒单克隆抗体的特性鉴定

通过ＳＤＳＰＡＧＥ、免疫印迹和相加ＥＬＩＳＡ分析了五株抗伪狂犬病病毒杂交瘤细胞系所分泌的单抗５Ｈ２、２Ｅ６、２Ｇ１１、３Ｄ１０和１Ｂ５（均为ＩｇＧ１）各自所识别的病毒多肽。结果证明：单抗５Ｈ２、２Ｅ６、２Ｇ１１和３Ｄ１０识别伪狂犬病病毒９７ＫＤ多肽，单抗１Ｂ５识别５４ＫＤ多肽。相加ＥＬＩＳＡ证实单抗５Ｈ２、２Ｅ６、２Ｇ１１和３Ｄ１０识别同一多肽的重叠表位或邻近表位。     

猪繁殖与呼吸道综合征病毒(PRRSV)单克隆抗体的研制

利用猪繁殖与呼吸道综合征病毒（ＰＲＲＳＶ）国内分离株Ｊ１,采用反复差速离心法制备免疫抗原,长程免疫法免疫ＢＡＬＢ／ｃ小鼠,用间接ＥＬＩＳＡ方法检测抗体,通过细胞融合技术,并经３次亚克隆获得了１０株能稳定分泌抗ＰＲＲＳＶ单抗的杂交瘤细胞单克隆株（Ａ１Ｄ７Ｈ１０,Ａ１Ｄ７Ｈ１１,Ａ１Ｅ７Ｈ９,Ａ１Ｅ７Ｄ９,Ａ２Ｄ８Ｅ７,Ａ２Ｄ８Ｂ１１,Ｂ３Ｄ１１Ｄ６,Ｂ２Ｇ９Ａ９,Ｂ２Ｇ９Ｆ２）。这些细胞经体外连续传     

鉴别狂犬病病毒强弱毒株中和性单克隆抗体的制备及初步应用

为获得对狂犬病病毒弱毒疫苗株筛选和糖蛋白抗原结构分析的单克隆抗体,将鹿狂犬病病毒 ８２０２ 株在适宜的条件下培养 ７２ ｈ,收集无细胞上清,经离心沉淀、 Ｚｎ （ Ａ Ｃ）２ 浓缩、１０％ ～５０％ 质量浓度的蔗糖密度梯度离心纯化、 Ｓ Ｄ Ｓ Ｐ Ａ Ｇ Ｅ 分析证明,产物中富含狂犬病病毒特异的结构蛋白。以上述纯化病毒免疫 Ｂ Ａ Ｌ Ｂ／ｃ 小鼠的脾细胞与 Ｓ Ｐ２／０ 骨髓瘤细胞融合,经 ３～５ 次克隆,间接 Ｅ Ｌ Ｉ Ｓ Ａ 筛选, Ｗ ｅｓｔｅｒｎ ｂｌｏｔｔｉｎｇ 鉴定,并与不同科病毒反应,建立了 ２ 株（４ Ａ５ ,３ Ａ５ ）可稳定分泌抗狂犬病病毒 Ｇ 蛋白的杂交瘤细胞株。这 ２ 株 Ｍ ｃ Ａｂ 与 ４株狂犬病病毒反应,经间接 Ｅ Ｌ Ｉ Ｓ Ａ 检测,发现能与强毒株反应,而与弱毒株不反应。细胞中和试验证实,这 ２株 Ｍ ｃ Ａｂ 具有良好的细胞中和活力。     

抗鸡IgG重链单克隆抗体的制备与应用

以提纯鸡ＩｇＧ做抗原免疫Ｂａｌｌ／ｃ小鼠，取鼠细胞在ＰＥＧ１０００作用下与小鼠骨髓细胞（Ｓｐ２／ｏＡｇ１４）融合，采用间接免疫荧光（ＩＦＡ）和酶联免疫吸附试验（ＥＬＩＳＡ）检测上清抗体，阳性孔经有限稀法进行细胞克隆，共获得了７株分泌抗鸡ＩｇＧ单克隆抗体的杂交瘤细胞（２Ｈ８、４Ｄ８、４Ｄ８、１Ｂ７、２Ａ７、２Ｂ３、１Ｇ１２、３Ｄ１２）将这些细胞分别接种间系小鼠制备出腹水抗体，ＥＬＩＳＡ效价可达１０＾     

分泌抗赭曲霉素A单克隆抗体杂交瘤细胞株的建立

用赭曲霉素Ａ（ＯＡ）－ＢＳＡ合成抗原免疫Ｂａｌｂ／ｃ小鼠，取免疫鼠脾细胞与ｓｐ２／０细胞融合，通过克隆和ＥＬＩＳＡ法筛选，建立三株泌抗ＯＡ单克隆抗体杂交瘤细胞株（３Ｃ１２，１Ｄ１２和２Ｇ７）。用间接ＥＬＩＳＡ法测定，细胞上清液抗体效价为１２８＾×（３Ｃ１２）和６４＾×（１Ｄ１２和２Ｇ７）腹水抗体效价为１０＾－７（３Ｃ１２，１Ｄ１２）和１０＾－６（２Ｇ７）。三株单抗（ＭｃＡｂ）均属ＩｇＧ类，分泌抗体     

抗A型产气荚膜梭菌α毒素单克隆抗体杂交瘤细胞系的建立与中和效应

用提取的 Ａ 型产气荚膜梭菌 α毒素包涵体免疫 Ｂ Ａ Ｌ Ｂ／ｃ 小鼠后， 取小鼠脾细胞与 Ｓ Ｐ２／０ 骨髓瘤细胞进行融合和克隆化，经间接 Ｅ Ｌ Ｉ Ｓ Ａ 筛选，共获得 １ Ａ８、１ Ｃ３、１ Ｄ５、１ Ｄ８、１ Ｆ１、１ Ｈ１ 和 ２ Ｅ３ ７ 株稳定分泌单克隆抗体（ Ｍ ｃ Ａｂ）的杂交瘤细胞株。经鉴定，７ 株 Ｍ ｃ Ａｂ 的 Ｉｇ 亚类有 Ｉｇ Ｇ１（１ Ｄ８）、 Ｉｇ Ｇ３（１ Ａ８、１ Ｃ３ 和 ２ Ｅ３）和 Ｉｇ Ｍ（１ Ｄ５、１ Ｆ１ 和 １ Ｈ１）。细胞培养上清和腹水抗体效价分别为 １∶５１２～１∶１ ０２４ 和 １∶１０６ ～１∶１０８ 。尤为重要的是，２ Ｅ３ 杂交瘤细胞株分泌的 Ｍ ｃ Ａｂ 不仅能够中和 α毒素的磷脂酶 Ｃ活性和溶血活性，而且能够对致死性腹腔感染小鼠产生良好的被动保护作用。     

禽病原性大肠杆菌I型菌毛单克隆抗体的研制及其对分离株的检测

从禽病原性大肠杆菌分离株ＴＫ３（Ｏ１）提取Ｉ型菌毛免疫ＢＡＩＢ／ｃ小鼠,取其脾细胞与小鼠骨髓瘤细胞融合,获得４株能稳定分泌针对Ｉ型菌毛的单克隆抗体杂交瘤细胞株,分别命名为ａＢ６、ｂＧ５、ｃＦ３和ｃＧ３。单克隆阻断甘露糖敏血凝试验,免疫胶体金和Ｗｅｓｔｅｒｎ ｂｌｏｔ试验证明,单抗是Ｉ型菌毛特异的。这些单抗培养上清及腹水的ＥＬＩＳＡ效价为分别为１０＾－２～１０＾－３和１０＾－５～１０＾－６;腹水的平     

具有中和活性的减蛋综合征病毒单抗的研制

用减蛋综合征病毒毒株ＷＰＤＶ２０５纯化抗原免疫ＢＡＬＢ／ｃ小鼠，在最后一次免疫后第３天取脾细胞与ＳＰ２／０细胞在ＰＥＧ－４０００的作用下融合。用间接ＥＬＩＳＡ初步筛选出阳性克隆１０株（４Ｂ１、１Ｄ４、２Ｄ６、３Ｄ６、３Ａ５、２Ａ１、３Ｃ６、３Ｃ１、１Ｂ３和２Ｃ５）。这些杂交瘤细胞经克隆化和再次检测后生产腹水，用微量细胞中和试验筛选出具有中和活性的单克抗隆体４株（４Ｂ１、３Ｃ１、３Ｃ６和２Ｃ５），其     

马立克氏病毒单克隆抗体的制备及应用

用ＭＤ１１／７５ｃ，ＳＢ１，ＨＶＴＦＣ１２６三个马立克氏病毒株分别兔疫Ｂａｌｂ／ｃ小鼠，获得１０株分泌抗马立克氏病毒单克隆抗体的杂交瘤细胞株，分别命名为ＦＭ３，ＦＭ１７，ＦＭ２４，ＦＭ２８，ＦＭ４２，ＦＭ４５，ＦＭ５２，ＦＭ５３，ＦＭ５４，ＦＭ１５９。这些单克隆抗体都具有免疫萤光反应特性，其腹水抗体的ＦＡ效价为１０＾３－１０＾５，其中ＦＭ３，ＦＭ４２，ＦＭ５３，ＦＭ１５９等单抗具有ＥＬＩＳＡ特性，     

白术、微米白术和白术多糖对断奶仔猪生长性能和肠道形态及微生态区系的影响

试验选用96头平均体重14.82 kg左右的杜×长×大断奶仔猪,随机分成4组,每组3栏,每栏8头(公母各半)。对照组饲喂基础日粮,试验1、2、3组分别添加1%80目白术、0.2%白术多糖和1%微米白术。试验期30 d。结果表明:在生长性能方面,与对照组相比,1%微米白术添加组可显著提高日增重(P0.05)、降低饲料增重比和腹泻率,而且效果优于1%80目白术组和0.2%白术多糖组,在肠道形态和肠道微生态区系方面,与对照组相比,日粮添加1%80目白术、0.2%白术多糖、1%微米白术均可不同程度的提高十二指肠和空肠的绒毛高度,加深十二指肠和空肠的隐窝深度,并且增加肠道微生态区系的多样性,其中以1%微米白术添加组的效果最佳。     

Prevalence and seasonal incidence of nematode parasites and fluke infections of sheep and goats in eastern Ethiopia

Sissay, M.M., Uggla, A. and Waller, P.J., XXXX. Prevalence and seasonal incidence of nematode parasites and fluke infections of sheep and goats in eastern Ethiopia. Tropical Animal Health and Production, XXXX. A 2-year abattoir survey was carried out to determine the prevalence, abundance and seasonal incidence of gastro-intestinal (GI) nematodes and trematodes (flukes) of sheep and goats in the semi-arid zone of eastern Ethiopia. During May 2003 to April 2005, viscera including liver, lungs and GI tracts were collected from 655 sheep and 632 goats slaughtered at 4 abattoirs located in the towns of Haramaya, Harar, Dire Dawa and Jijiga in eastern Ethiopia. All animals were raised in the farming areas located within the community boundaries for each town. Collected materials were transported within 24 h to the parasitology laboratory of Haramaya University for immediate processing. Thirteen species belonging to 9 genera of GI nematodes (Haemonchus contortus, Trichostrongylus axei, T. colubriformis, T. vitrinus, Nematodirus filicollis, N. spathiger, Oesophagostomum columbianum, O. venulosum, Strongyloides papillosus, Bunostomum trigonocephalum, Trichuris ovis, Cooperia curticei and Chabertia ovina), and 4 species belonging to 3 genera of trematodes (Fasciola hepatica, F. gigantica, Paramphistomum {Calicohoron} microbothrium and Dicrocoelium dendriticum) were recorded in both sheep and goats. All animals in this investigation were infected with multiple species to varying degrees. The mean burdens of adult nematodes were generally moderate in both sheep and goats and showed patterns of seasonal abundance that corresponded with the bi-modal annual rainfall pattern, with highest burdens around the middle of the rainy season. In both sheep and goats there were significant differences in the mean worm burdens and abundance of the different nematode species between the four geographic locations, with worm burdens in the Haramaya and Harar areas greater than those observed in the Dire Dawa and Jijiga locations. Similar seasonal variations were also observed in the prevalence of flukes. But there were no significant differences in the prevalence of each fluke species between the four locations. Overall, the results showed that Haemonchus, Trichostrongylus, Nematodirus, Oesophagostomum, Fasciola and Paramphistomum species were the most abundant helminth parasites of sheep and goats in eastern Ethiopia.     

Phase I evaluation of CCNU (lomustine) in tumor-bearing cats

1-(2-Chloroethyl)3-cyclohexyl-1-nitrosourea (CCNU) is an alkylating agent in the nitrosourea subclass. A prospective evaluation of CCNU was done to determine the maximally tolerated dosage of CCNU in tumor-bearing cats. Response data were obtained when available. Twenty-five cats were treated with CCNU at a dosage of 50-60 mg/m3 body surface area. Complete hematologic data were available for 13 cats. Neutropenia was the acute dose-limiting toxicity. The median neutrophil count at the nadir was 1,000 cells/microL (mean, 2,433 cells/microL; range, 0-9,694 cells/microL). The time of neutrophil nadir was variable, occurring 7-28 days after treatment, and counts sometimes did not return to normal for up to 14 days after the nadir. Based on these findings, a 6-week dosing interval and weekly hematologic monitoring after the 1st treatment with CCNU are recommended. The nadir of the platelet count may occur 14-21 days after treatment. The median platelet count at the nadir was 43,500 cells/microL. No gastrointestinal, renal, or hepatic toxicities were observed after a single CCNU treatment, and additional studies to evaluate the potential for cumulative toxicity should be performed. Five cats with lymphoma and 1 cat with mast cell tumor had measurable responses to CCNU. Phase II studies to evaluate antitumor activity should be completed with a dosing regimen of 50-60 mg/m3 every 6 weeks.     

Y‐chromosomal variation of local goat breeds of Turkey close to the domestication centre

Genetic variations in chromosome Y are enabling researchers to identify paternal lineages, which are informative for introgressions and migrations. In this study, the male‐specific region markers, sex‐determining region‐Y (SRY), amelogenin (AMELY) and zinc finger (ZFY) were analysed in seven Turkish native goat breeds, Angora, Kilis, Hair, Honaml?, Norduz, Gürcü and Abaza. A SNP in the ZFY gene defined a new haplotype Y2C. All domestic haplogroups originate from Capra aegagrus, while the finding of Y1A, Y1B, Y2A and Y2C in 32, 4, 126 and 2 Turkish domestic goats, respectively, appears to indicate a predomestic origin of the major haplotypes. The occurrence of four haplotypes in the Hair goat and, in contrast, a frequency of 96% of Y1A in the Kilis breed illustrate that Y‐chromosomal variants have a more breed‐dependent distribution than mitochondrial or autosomal DNA. This probably reflects male founder effects, but a role in adaptation cannot be excluded.     

Furosemide continuous rate infusion in the horse: evaluation of enhanced efficacy and reduced side effects

Continuous rate infusion (CRI) of furosemide in humans is considered superior to intermittent administration (IA). This study examined whether furosemide CRI, compared with IA, would increase diuretic efficacy with decreased fluid and electrolyte fluctuations and activation of the renin-angiotensin-aldosterone system (RAAS) in the horse. Five mares were used in a crossover-design study. During a 24-hour period, each horse received a total of 3 mg/kg furosemide by either CRI (0.12 mg/kg/h preceded by a loading dose of 0.12 mg/kg IV) or IA (1 mg/kg IV q8h). There was not a statistically significant difference in urine volume over 24 hours between methods; however, urine volume was significantly greater after CRI compared with IA during the first 8 hours ([median 25th percentile, 75th percentile]: 9.6 L [8.9, 14.4] for CRI versus 5.9 L [5.3, 6.0] for IA). CRI produced a more uniform urine flow, decreased fluctuations in plasma volume, and suppressed renal concentrating ability throughout the infusion period. Potassium, Ca, and Cl excretion was greater during CRI than IA (1,133 mmol [1.110, 1,229] versus 764 mmol [709, 904], 102.7 mmol [96.0, 117.2] versus 73.3 mmol [65.0, 73.5], and 1,776 mmol [1,657, 2.378] versus 1,596 mmol [1,457, 1,767], respectively). Elimination half-lives of furosemide were 1.35 and 0.47 hours for CRI and IA, respectively. The area under the excretion rate curve was 1,285.7 and 184.2 mL x mg/mL for CRI and IA, respectively. Furosemide CRI (0.12 mg/kg/h) for 8 hours, preceded by a loading dose (0.12 mg/kg), is recommended when profound diuresis is needed acutely in horses.     

The Epidemiology of Gastrointestinal Nematodes of Dairy Cattle in Central Kenya

The epidemiology of H. placei and of other gastrointestinal nematodes in yearling dairy cattle was examined on two farms in Kiambu District, central Kenya during each of 13 one-month periods from April 1993 to April 1994. On each farm, 32 newly weaned dairy calves were given a single dose of albendazole and then placed on experimental pastures. Twelve of the animals were designated for bi-monthly slaughter (n = 2) and analysis of worm population characteristics and 20 were designated for blood and faecal collection and for weighing. Two parasite-free tracer calves were grazed alongside the weaner calves each month throughout the study period and were also slaughtered for analysis of worm populations. Faecal egg counts, haematological and serum pepsinogen determinations, herbage larval counts, and animal live weight changes were recorded monthly. The study revealed that Haemonchus placei, Trichostrongylus axei, Cooperia spp. and Oesophagostomum radiatum were responsible for parasitic gastroenteritis and that H. placei was the predominant nematode present in the young cattle on both farms. Faecal egg counts from resident cattle and necropsy worm counts revealed that pasture larval levels were directly related to the amount of rainfall. The total worm burdens in the animals were highest during the rainy season (March–June and October–December) and lowest during the dry seasons (July–September and January–February). The very low recovery of immature larvae of H. placei from the tracer calves indicated that arrested development is not a feature of the life cycle of this parasite in central Kenya. The maintenance of the parasite population depended on continuous cycling of infection between the host and the pasture. The agroclimatic conditions of the study area were such that, in general, favourable weather conditions for the development and survival of the free-living stages of gastrointestinal nematodes existed all year round.     

Diversity of Ectoparasites in Sheep Flocks in Sa~o Paulo,Brazil

The occurrence of ectoparasites in sheep flocks is frequently reported but seldom quantified. Sheep production used to be a predominantly family activity in the state of Sa~o Paulo (Brazil), but it began to become a commercial activity in the past decade. Thus, information about the ectoparasites existing in sheep flocks has become necessary. The present data were obtained by means of questionnaires sent to all sheep breeders belonging to the `Associaça~o Paulista de Criadores de Ovinos' (ASPACO; Sa~o Paulo State Association of Sheep Breeders). Response reliability was tested by means of random visits paid to 10.6% of the respondents. Most of the properties (89.5%) reported the presence of one or more ectoparasites. Screw-worm (Cochliomyia hominivorax) was the most frequent ectoparasite (72.5%), followed by bot fly larvae (Dermatobia hominis, 45.0%), ticks (Amblyomma cajennense) and Boophilus microplus, 31.3%) and finally lice (Damalinia ovis, 13.8%). Combined infestations also occurred, the most common one being screw-worm with bot fly larvae (36.0%) followed by bot fly larvae with ticks (13.9%), screw-worm with ticks (9.3%), bot fly larvae with lice (6.9%), and ticks with lice (5.0%). The most common triple combination was screw-worm, bot fly larvae and ticks (12.8%). Breeds raised for meat or wool were attacked by bot fly larvae and ticks more often than other breeds. Lice were only absent from animals of indigenous breeds. The relationships among these ectoparasites are discussed in terms of sheep breeds, flock size, seasonality and the ectoparasitic combinations on the host.     

Feline intracranial neoplasia: retrospective review of 160 cases (1985-2001)

The purpose of this study was to determine the frequency of different tumor types within a large cohort of cats with intracranial neoplasia and to attempt to correlate signalment, tumor size and location, and survival time for each tumor. Medical records of 160 cats with confirmed intracranial neoplasia evaluated between 1985 and 2001 were reviewed. Parameters evaluated included age, sex, breed, FeLV/FIV status, clinical signs, duration of signs, number of tumors, tumor location(s), imaging results, treatment, survival times, and histopathologic diagnosis. Most of the cats were older (11.3 +/- 3.8 years). Primary tumors accounted for 70.6% of cases. Metastasis and direct extension of secondary tumors accounted for only 5.6 and 3.8% of cases, respectively. Twelve cats (7.5%) had 2 or more discrete tumors of the same type, whereas 16 cats (10.0%) had 2 different types of intracranial tumors. The most common tumor types were meningioma (n = 93, 58.1%), lymphoma (n = 23, 14.4%), pituitary tumors (n = 14, 8.8%), and gliomas (n = 12, 7.5%). The most common neurological signs were altered consciousness (n = 42, 26.2%), circling (n = 36, 22.5%), and seizures (n = 36, 22.5%). Cats without specific neurological signs were common (n = 34, 21.2%). The tumor was considered an incidental finding in 30 (18.8%) cats. In addition to expected relationships (eg, meninges and meningioma, pituitary and pituitary tumors), we found that lesion location was predictive of tumor type with diffuse cerebral or brainstem involvement predictive of lymphoma and third ventricle involvement predictive of meningioma.     

A brief history of the prevention of infectious diseases by immunisations

Infectious diseases have always been a terrible scourge for humans. The appearance of these plagues, as they were called without distinction, was generally connected to various conditions: asters, climatic changes or religious reasons. The concept of contagious, and then infectious, diseases came slowly. Variolation, i.e. transmission of ‘virulent’ matter to induce a natural disease and the immunity against it, was brought from Constantinople to England by Lady Montague, in 1721. This ‘variolation’ technique was also often performed in veterinary medicine against diseases like sheep-pox or pleuropneumonia. As ‘vaccination’ is the term generally accepted for ‘immunisation’, variolation can be the word designating such a technique. The second period of the history of immunisation began, in 1880, with the studies of Pasteur and his collaborators. A great number of bacterial vaccines were developed: dead, live but attenuated or only parts of pathogens. The viruses were produced in animals, then in eggs and at last, in tissue cultures. Second generation vaccines appeared with genetic engineering: recombinant vaccines, vector vaccines, nucleic acids vaccines, and markers vaccines, among others. These novel technologies can permit the development of new ones and improve the quality of the vaccines already existing.